Breyer, J., Erben, P., Rinaldetti, S., & Worst, T. (2019). FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer. BJU international, 123(1), . https://doi.org/10.1111/bju.14525
Chicago-Zitierstil (17. Ausg.)Breyer, Johannes, Philipp Erben, Sébastien Rinaldetti, und Thomas Worst. "FOXM1 Overexpression Is Associated with Adverse Outcome and Predicts Response to Intravesical Instillation Therapy in Stage PT1 Non-muscle-invasive Bladder Cancer." BJU International 123, no. 1 (2019). https://doi.org/10.1111/bju.14525.
MLA-Zitierstil (9. Ausg.)Breyer, Johannes, et al. "FOXM1 Overexpression Is Associated with Adverse Outcome and Predicts Response to Intravesical Instillation Therapy in Stage PT1 Non-muscle-invasive Bladder Cancer." BJU International, vol. 123, no. 1, 2019, https://doi.org/10.1111/bju.14525.